Who is sponsoring NCT03784118?

NCT03784118 is sponsored by Seoul National University Hospital.

What drugs are being tested in NCT03784118?

Interventions in NCT03784118: Ultrasonography, perfusion index.

What condition does NCT03784118 study?

NCT03784118 studies Complications After Arterial Catheterization.

Is NCT03784118 still recruiting?

NCT03784118 is currently completed. Last updated 17 October 2024.

Last reviewed 2024-10-17 · How we verify

NCT03784118

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Complications Associated with Arterial Line Placement in Children

Completed NA Last updated 17 October 2024

What this trial tests

NA trial testing Ultrasonography in Complications After Arterial Catheterization in 82 participants. Completed in 2 September 2023.

Timeline

10 January 2019

Primary endpoint
31 August 2023

2 September 2023

Quick facts

Lead sponsor	Seoul National University Hospital
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	screening
Enrollment	82
Start date	10 January 2019
Primary completion	31 August 2023
Estimated completion	2 September 2023
Sites	1 location across South Korea

Drugs / interventions tested

Ultrasonography
perfusion index

Conditions studied

Complications After Arterial Catheterization — all drugs for Complications After Arterial Catheterization →

Sponsor

Seoul National University Hospital

Who can join

Under 5, any sex, with Complications After Arterial Catheterization. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to find the risk factors for complications following arterial line catheterization. Ultrasonography is used to evaluate the size of artery which is cannulated, before and after catheterization. The complications include ischemia, bleeding, thrombosis and so on.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Immediate complications and risk factors following radial arterial catheterisation in paediatric patients at a tertiary centre.
Lee JH, Park JB, Ji SH, Jang YE, et al · · 2026 · PMID 40923190 · DOI 10.1097/eja.0000000000002268

Verify or expand the search:

Other trials of Ultrasonography

Trials testing the same drug.

NCT07406061 — Ultrasound Imaging of the Head, Neck, and Airway · not yet recruiting
NCT07144501 — Prevalence of Liver Dysfunction in Pediatric Patients With Congenital Heart Disease at Assiut. · NA · not yet recruiting
NCT06492603 — Examination of Biomechanical Characteristics of Linea Alba in Diastasis Recti Patients · not yet recruiting
NCT02492932 — The Second Try During Landmark Approach of the Internal Jugular Vein: an Ultrasonographic Prelocation Study · NA · not yet recruiting
NCT06778005 — Investigation of Ultrasonographic Measurements of Lower Extremity Nerves in Type 2 Diabetes Patients With Peripheral Pol · recruiting

Other Seoul National University Hospital trials

Trials by the same sponsor.

NCT07262944 — EOI Block in Otoplasty With Rib Cartilage Graft · NA · recruiting
NCT07464210 — Nemtabrutinib, Bortezomib, and Rituximab for WM · Phase 2 · not yet recruiting
NCT07550803 — Effect of Intraoperative Dexamethasone on Early Postoperative Sleep Quality in Patients Undergoing Nasal Surgery · NA · not yet recruiting
NCT07522138 — Home-based Self-exercise in Patients With Parkinson's Disease: A Feasibility Study · NA · not yet recruiting
NCT07476651 — Scout Dose of Resin Microspheres · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03784118 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Seoul National University Hospital
Last refreshed: 17 October 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03784118.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing